Insiders Cyxone AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
0.104 ^SEK	+16.20%		+1.96%	+3.59%

May. 14	Cyxone AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Sweden's Cyxone Appoints New CEO	MT

Sweden's Cyxone Appoints New CEO	Apr. 22	MT
Cyxone AB Announces Chief Executive Officer Changes	Apr. 22	CI
Cyxone AB Announces Board Changes	23-05-30	CI
Cyxone AB Announces Board Resignations	23-04-26	CI
Cyxone Confirms Acting CEO with Permanent Appointment	22-12-13	MT
Cyxone AB Appoints Carl-Magnus Högerkorp as Permanent CEO	22-12-13	CI
Cyxone AB Announces That the Members of the Nomination Committee for Annual General Meeting 2023	22-11-08	CI
Cyxone Appoints Erika Samuelsson as Chief Development Officer	22-09-22	CI
Biotech Company Cyxone Appoints New Chief Development Officer	22-09-02	MT
Cyxone AB Appoints Erika Samuelsson as Chief Development Officer	22-09-02	CI
Swedish Drugmaker Cyxone CEO Departs	22-06-21	MT
Cyxone Announces Executive Changes	22-06-20	CI
Swedish Biotech Firm Cyxone's Chief Medical Officer Exits	22-02-23	MT
Cyxone Announces Resignation of Cornel Pater as Chief Medical Officer	22-02-23	CI
Cyxone AB Appoints Cornel Pater as New Chief Medical Officer	21-09-01	CI
Cyxone AB Appoints Ola Skanung as Senior Executive Advisor	21-06-09	CI
Cyxone AB Elects Peter Heinrich and Alejandra Mørk as New Board Members	21-06-03	CI
Cyxone AB Announces Executive Changes	21-05-25	CI
Christin Arrhenius Bokedal to Join Cyxone AB as Head of Development	20-09-08	CI
Cyxone AB Signs Agreement with Professor Rikard Holmdahl as Senior Scientific Advisor	20-07-08	CI

No results for this search